Inventor

ALBITAR MAHER

US57 patents

⚠️ This page may combine multiple inventors who share the name “ALBITAR MAHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALBITAR MAHER

QUEST DIAGNOSTICS INVEST INC

Methods for detecting gene dysregulation by intragenic differential expression

Methods for detecting gene dysregulation by intragenic differential expression

Methods for detecting gene dysregulation by intragenic differential expression

EML4-ALK translocations in lung cancer

Compositions and methods for detecting mutations in JAK2 nucleic acid

BCR-ABL truncation mutations

EML4-ALK translocations in lung cancer

BCR-ABL variants

Hematopoietic cell phenotyping using circulating cell-free markers

TMPRSS2 for the diagnosis of prostate disease

Methods for detecting TCR-gamma gene rearrangement

Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders

Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders

MPL mutations in JAK2 V617F negative patients with myeloproliferative disease

Circulating microRNA as a marker for hepatocellular carcinoma

QUEST DIAGNOSTICS INVEST LLC

EML4-ALK translocations in lung cancer

BCR-ABL truncation mutations

Compositions and methods for detecting mutations in JAK2 nucleic acid

Compositions and methods for detecting mutations in JAK2 nucleic acid

EML4-ALK translocations in lung cancer

BCR-ABL variants

Hematopoietic cell phenotyping using circulating cell-free markers

Circulating microRNA as a marker for hepatocellular carcinoma

BCR-ABL variants

Methods for detecting gene dysregulation by intragenic differential expression

Methods for detecting gene dysregulation by intragenic differential expression

ALBITAR MAHER

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

BCR-ABL variants

Assay for detecting genetic abnormalities in genomic nucleic acids

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Compositions and methods for detecting mutations in JAK2 nucleic acid

BCR-ABL truncation mutations

Hematopoietic cell phenotyping using circulating cell-free markers

UNIV TEXAS

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies

NEOGENOMICS LABORATORIES INC

Method for high sensitivity detection of MYD88 mutations

Method to increase sensitivity of detection of low-occurrence mutations

High-sensitivity sequencing to detect BTK inhibitor resistance

Deep sequecing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of myelodysplastic syndrome

Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma

SANDERS HEATHER R

Methods for detecting gene dysregulation by intragenic differential expression

EML4-ALK translocations in lung cancer

NEOGENOMICS LAB

Automated fish reader using learning machines

HEALTH DISCOVERY CORP

Computer-assisted karyotyping

MA WANLONG

MPL mutations in JAK2 V617F negative patients with myeloproliferative disease